1152 related articles for article (PubMed ID: 23596044)
1. Immune responses to AAV vectors: overcoming barriers to successful gene therapy.
Mingozzi F; High KA
Blood; 2013 Jul; 122(1):23-36. PubMed ID: 23596044
[TBL] [Abstract][Full Text] [Related]
2. AAV Vector Immunogenicity in Humans: A Long Journey to Successful Gene Transfer.
Verdera HC; Kuranda K; Mingozzi F
Mol Ther; 2020 Mar; 28(3):723-746. PubMed ID: 31972133
[TBL] [Abstract][Full Text] [Related]
3. Adeno-associated virus (AAV) vectors in gene therapy: immune challenges and strategies to circumvent them.
Hareendran S; Balakrishnan B; Sen D; Kumar S; Srivastava A; Jayandharan GR
Rev Med Virol; 2013 Nov; 23(6):399-413. PubMed ID: 24023004
[TBL] [Abstract][Full Text] [Related]
4. Pre-existing antibodies to candidate gene therapy vectors (adeno-associated vector serotypes) in domestic cats.
Li P; Boenzli E; Hofmann-Lehmann R; Helfer-Hungerbuehler AK
PLoS One; 2019; 14(3):e0212811. PubMed ID: 30897117
[TBL] [Abstract][Full Text] [Related]
5. Genetic Engineering of AAV Capsid Gene for Gene Therapy Application.
Liu Y; Zhang X; Yang L
Curr Gene Ther; 2020; 20(5):321-332. PubMed ID: 32998676
[TBL] [Abstract][Full Text] [Related]
6. The complex and evolving story of T cell activation to AAV vector-encoded transgene products.
Mays LE; Wilson JM
Mol Ther; 2011 Jan; 19(1):16-27. PubMed ID: 21119617
[TBL] [Abstract][Full Text] [Related]
7. Adeno-associated virus as a gene therapy vector: strategies to neutralize the neutralizing antibodies.
Lotfinia M; Abdollahpour-Alitappeh M; Hatami B; Zali MR; Karimipoor M
Clin Exp Med; 2019 Aug; 19(3):289-298. PubMed ID: 31054018
[TBL] [Abstract][Full Text] [Related]
8. Immune responses to adeno-associated virus vectors.
Zaiss AK; Muruve DA
Curr Gene Ther; 2005 Jun; 5(3):323-31. PubMed ID: 15975009
[TBL] [Abstract][Full Text] [Related]
9. Pre-existing anti-adeno-associated virus antibodies as a challenge in AAV gene therapy.
Louis Jeune V; Joergensen JA; Hajjar RJ; Weber T
Hum Gene Ther Methods; 2013 Apr; 24(2):59-67. PubMed ID: 23442094
[TBL] [Abstract][Full Text] [Related]
10. From virus evolution to vector revolution: use of naturally occurring serotypes of adeno-associated virus (AAV) as novel vectors for human gene therapy.
Grimm D; Kay MA
Curr Gene Ther; 2003 Aug; 3(4):281-304. PubMed ID: 12871018
[TBL] [Abstract][Full Text] [Related]
11. Developing immunologically inert adeno-associated virus (AAV) vectors for gene therapy: possibilities and limitations.
Selot RS; Hareendran S; Jayandharan GR
Curr Pharm Biotechnol; 2014; 14(12):1072-82. PubMed ID: 24678652
[TBL] [Abstract][Full Text] [Related]
12. Immune responses to AAV in clinical trials.
Mingozzi F; High KA
Curr Gene Ther; 2011 Aug; 11(4):321-30. PubMed ID: 21557723
[TBL] [Abstract][Full Text] [Related]
13. Immune responses to AAV in clinical trials.
Mingozzi F; High KA
Curr Gene Ther; 2007 Oct; 7(5):316-24. PubMed ID: 17979678
[TBL] [Abstract][Full Text] [Related]
14. Impact of AAV Capsid-Specific T-Cell Responses on Design and Outcome of Clinical Gene Transfer Trials with Recombinant Adeno-Associated Viral Vectors: An Evolving Controversy.
Ertl HCJ; High KA
Hum Gene Ther; 2017 Apr; 28(4):328-337. PubMed ID: 28042943
[TBL] [Abstract][Full Text] [Related]
15. Enhancing transduction of the liver by adeno-associated viral vectors.
Nathwani AC; Cochrane M; McIntosh J; Ng CY; Zhou J; Gray JT; Davidoff AM
Gene Ther; 2009 Jan; 16(1):60-9. PubMed ID: 18701909
[TBL] [Abstract][Full Text] [Related]
16. Immunogenicity of Recombinant Adeno-Associated Virus (AAV) Vectors for Gene Transfer.
Arjomandnejad M; Dasgupta I; Flotte TR; Keeler AM
BioDrugs; 2023 May; 37(3):311-329. PubMed ID: 36862289
[TBL] [Abstract][Full Text] [Related]
17. Adeno-Associated Viruses (AAV) and Host Immunity - A Race Between the Hare and the Hedgehog.
Rapti K; Grimm D
Front Immunol; 2021; 12():753467. PubMed ID: 34777364
[TBL] [Abstract][Full Text] [Related]
18. Unraveling the Complex Story of Immune Responses to AAV Vectors Trial After Trial.
Vandamme C; Adjali O; Mingozzi F
Hum Gene Ther; 2017 Nov; 28(11):1061-1074. PubMed ID: 28835127
[TBL] [Abstract][Full Text] [Related]
19. Immunity to adeno-associated virus vectors in animals and humans: a continued challenge.
Zaiss AK; Muruve DA
Gene Ther; 2008 Jun; 15(11):808-16. PubMed ID: 18385765
[TBL] [Abstract][Full Text] [Related]
20. Antibody neutralization poses a barrier to intravitreal adeno-associated viral vector gene delivery to non-human primates.
Kotterman MA; Yin L; Strazzeri JM; Flannery JG; Merigan WH; Schaffer DV
Gene Ther; 2015 Feb; 22(2):116-26. PubMed ID: 25503696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
